Seres Therapeutics
-$0.74 (-3.28%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
You can buy or sell MCRB and other stocks, options, and ETFs commission-free!
About MCRB
Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401.
CEO
Eric D. Shaff
Employees
155
Headquarters
Cambridge, Massachusetts
Founded
2010
MCRB Key Statistics
Market Cap
2.15B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
967.59K
High Today
$22.70
Low Today
$20.87
Open Price
$22.08
Volume
632.64K
52 Week High
$38.50
52 Week Low
$3.67
Analyst Ratings
78%
of 9 ratings
Buy
77.8%
Hold
22.2%
Sell
0%
MCRB Earnings
-$0.39
-$0.26
-$0.13
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.31 per share
Actual
-$0.39 per share